Transmission of meropenem in breast milk

Pediatric Infectious Disease Journal

Volumn 31, Issue 8, 2012, Pages 832-834

  Sauberan, Jason B ^a   Bradley, John S ^b,c   Blumer, Jeffrey ^d   Stellwagen, Lisa M ^a,c  

^a UCSD MEDICAL CENTER   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

breast milk; lactation; meropenem

Indexed keywords

CEFALEXIN; MEROPENEM;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BREAST FEEDING; BREAST MILK; CASE REPORT; DRUG DISTRIBUTION; DRUG EXPOSURE; DRUG SUBSTITUTION; DRUG TRANSPORT; DYSURIA; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HOSPITAL DISCHARGE; HUMAN; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PRIORITY JOURNAL; PUERPERIUM; URINALYSIS; URINARY TRACT INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; BREAST FEEDING; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INFANT, NEWBORN; LACTATION; MILK, HUMAN; PREGNANCY; THIENAMYCINS; URINARY TRACT INFECTIONS;

EID: 84863922056     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318256f4bf     Document Type: Article

References (20)

1. Tita AT, Andrews WW. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol. 2010;37:339-354.
2. Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1-36.
3. ACOG Practice Bulletin No. 80: premature rupture of membranes Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol. 2007;109:1007-1019.
4. Smaill FM, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 2007;Issue 2:CD000490.
5. Dubois V, De Barbeyrac B, Rogues AM, et al. CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission. J Antimicrob Chemother. 2010;65:1368-1371.
6. Blaschke AJ, Korgenski EK, Daly JA, et al. Extended-spectrum beta-lactamase-producing pathogens in a children's hospital: a 5-year experience. Am J Infect Control. 2009;37:435-441.
7. Patel SJ, Saiman L. Antibiotic resistance in neonatal intensive care unit pathogens: mechanisms, clinical impact, and prevention including antibiotic stewardship. Clin Perinatol. 2010;37:547-563.
8. Bizzarro MJ, Gallagher PG. Antibiotic-resistant organisms in the neonatal intensive care unit. Semin Perinatol. 2007;31:26-32.
9. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother. 2011;66:1-14.
10. Shakil S, Akram M, Ali SM, et al. Acquisition of extended-spectrum beta-lactamase producing Escherichia coli strains in male and female infants admitted to a neonatal intensive care unit: molecular epidemiology and analysis of risk factors. J Med Microbiol. 2010;59(pt 8):948-954.
11. Begg EJ, Duffull SB, Saunders DA, et al. Paroxetine in human milk. Br J Clin Pharmacol. 1999;48:142-147.
12. Begg EJ, Duffull SB, Hackett LP, et al. Studying drugs in human milk: time to unify the approach. J Hum Lact. 2002;18:323-332.
13. Chung AM, Reed MD, Blumer JL. Antibiotics and breast-feeding: a critical review of the literature. Paediatr Drugs. 2002;4:817-837.
14. National Library of Medicine Toxnet Toxicology Data Network. Imipenem Drugs and Lactation Database (LactMed) 2010. Available at: http://toxnet. nlm.nih.gov/cgi-bin/sis/htmlgen?LACT Accessed February 7, 2011.
15. Blumer JL. Pharmacokinetic determinants of carbapenem therapy in neonates and children. Pediatr Infect Dis J. 1996;15:733-737.
16. Zhanel GG, Wiebe R, Dilay L, et al. Comparative review of the carbapenems. Drugs. 2007;67:1027-1052.
17. Bradley JS, Sauberan JB, Ambrose PG, et al. Meropenem pharmacokinetics, pharmacodynamics, and Monte Carlo simulation in the neonate. Pediatr Infect Dis J. 2008;27:794-799.
18. Moon YS, Chung KC, Gill MA. Pharmacokinetics of meropenem in animals, healthy volunteers, and patients. Clin Infect Dis. 1997;24(suppl 2):S249-S255.
19. Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology-drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349:1157-1167.
20. Huang NN, High RH. Comparison of serum levels following the administration of oral and parenteral preparations of penicillin to infants and children of various age groups. J Pediatr. 1953;42:657-658.